Doxorubicin–transferrin conjugate triggers pro-oxidative disorders in solid tumor cells
- 1 March 2016
- journal article
- Published by Elsevier in Toxicology in Vitro
- Vol. 31, 60-71
Abstract
No abstract availableKeywords
Funding Information
- University of Lodz, Poland (B1511000001026.02)
This publication has 34 references indexed in Scilit:
- The G671V variant of MRP1/ABCC1 links doxorubicin-induced acute cardiac toxicity to disposition of the glutathione conjugate of 4-hydroxy-2-trans-nonenalPharmacogenetics and Genomics, 2012
- The transferrin receptor and the targeted delivery of therapeutic agents against cancerBiochimica et Biophysica Acta (BBA) - General Subjects, 2012
- Reduced creatine-stimulated respiration in doxorubicin challenged mitochondria: Particular sensitivity of the heartBiochimica et Biophysica Acta (BBA) - Bioenergetics, 2007
- Dual-ligand effect of transferrin and transforming growth factor alpha on polyethyleneimine-mediated gene deliveryJournal of Controlled Release, 2007
- Necrotic death without mitochondrial dysfunction-delayed death of cardiac myocytes following oxidative stressBiochimica et Biophysica Acta (BBA) - Molecular Cell Research, 2007
- Polymer Therapeutics: Concepts and ApplicationsAngewandte Chemie International Edition, 2006
- Mechanisms of induction of apoptosis by anthraquinone anticancer drugs aclarubicin and mitoxantrone in comparison with doxorubicin: Relation to drug cytotoxicity and caspase-3 activationApoptosis, 2005
- Anthracyclines: Molecular Advances and Pharmacologic Developments in Antitumor Activity and CardiotoxicityPharmacological Reviews, 2004
- Influence of conjugation of doxorubicin to transferrin on the iron uptake by K562 cells via receptor‐mediated endocytosisEuropean Journal of Biochemistry, 1993
- Human Hepatocellular Carcinoma Cell Lines Secrete the Major Plasma Proteins and Hepatitis B Surface AntigenScience, 1980